findmyKOL
Clinical trialNCT01148550SuspendedObservational

Longitudinal Study of Mitochondrial Hepatopathies

SponsorArbor Research Collaborative for HealthEnrollment90Acute Liver FailureDisorder of Fatty Acid OxidationEnd Stage Liver DiseaseMitochondrial DiseasesRespiratory Chain Deficiencies, Mitochondrial
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The specific aims of this study are (1) to determine the clinical phenotypes and natural history of hepatic RC and FAO disorders, (2) to determine the correlation between genotype and phenotype, (3) to determine if circulating biomarkers reflect diagnosis and predict liver disease progression and survival with the native liver, (4) to determine the clinical outcome of these disorders following liver transplantation, and (5) to develop a repository of serum, plasma, urine, tissue and DNA specimens that will be used in ancillary studies. To accomplish these aims, the ChiLDReN investigators at clinical sites (currently 9 sites) will prospectively collect defined data and specimens in a uniform fashion at fixed intervals in a relatively large number of subjects. Clinical information collected from subjects and their parents will enhance the potential for meaningful research in these disorders. A biobank of previously collected subject specimens and DNA samples will be established for use in ancillary studies to be performed in addition to this study.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Hospital for Sick Children

    Toronto, Ontario, Canada

United States
  • Children'S Hospital Los Angeles

    Los Angeles, California, United States

  • University of California at San Francisco (ucsf)

    San Francisco, California, United States

  • Children'S Hospital Colorado

    Aurora, Colorado, United States

  • Children'S Healthcare of Atlanta - Emory University

    Atlanta, Georgia, United States

  • Ann & Robert H. Lurie Children'S Hospital

    Chicago, Illinois, United States

  • Riley Hospital for Children

    Indianapolis, Indiana, United States

  • Johns Hopkins School of Medicine

    Baltimore, Maryland, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Mount Sinai Medical Center

    New York, New York, United States

  • Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

  • the Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

  • Upmc Children'S Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Texas Children'S Hospital (baylor College of Medicine)

    Houston, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

  • Seattle Children'S Hospital

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Aug 2010
Primary completion
31 May 2029
Completion
31 May 2029
Last update posted
4 Jun 2026
Registered enrollment
90
Registry id
NCT01148550

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.